[CAS NO. 63236-23-7] Pareptide monohydrochloride
PRODUCTS SPECIFICATIONS [63236-23-7]
DESCRIPTION [63236-23-7]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 334.84 |
| Molecular Formula | C14H27ClN4O3 |
| SMILES | O=C([C@@H]1CCCN1)N(C)[C@H](CC(C)C)C(NCC(N)=O)=O.Cl |
Summary
Pareptide monohydrochloride is a melanotropin-inhibiting factor (MIF) metabolically stable analogue.
In Vivo
Chronic coadministration of Pareptide (0.25 mg/kg, SC, BID, 3.5 days) to mice pretreated with Haloperidol (8.0 mg/kg, IP, BID, 3 days) significantly increases the cataleptic effects of a smaller challenge dose of Haloperidol (2.0 mg/kg, IP) given 15 hours after the last pretreatment injections (p<0.01) [1] .
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
